These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33328257)

  • 41. Interface management concepts in healthcare for rare diseases in Germany: a study protocol for a mixed-methods study to develop best practice recommendations.
    Inhestern L; Zybarth D; Otto R; Brandt M; Härter M; Bergelt C
    BMJ Open; 2020 Nov; 10(11):e040470. PubMed ID: 33257484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using a community advisory board to develop a serious game for older adults undergoing treatment for cancer.
    Loerzel V; Clochesy J; Geddie P
    Appl Nurs Res; 2018 Feb; 39():207-210. PubMed ID: 29422160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partnering with community-based organizations: an academic institution's evolving perspective.
    Norris KC; Brusuelas R; Jones L; Miranda J; Duru OK; Mangione CM
    Ethn Dis; 2007; 17(1 Suppl 1):S27-32. PubMed ID: 17598314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.
    Barger S; Sullivan SD; Bell-Brown A; Bott B; Ciccarella AM; Golenski J; Gorman M; Johnson J; Kreizenbeck K; Kurttila F; Mason G; Myers J; Seigel C; Wade JL; Walia G; Watabayashi K; Lyman GH; Ramsey SD
    BMC Med Res Methodol; 2019 Jun; 19(1):119. PubMed ID: 31185918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing and evaluating a lay health worker delivered implementation intervention to decrease engagement disparities in behavioural parent training: a mixed methods study protocol.
    Barnett M; Miranda J; Kia-Keating M; Saldana L; Landsverk J; Lau AS
    BMJ Open; 2019 Jul; 9(7):e028988. PubMed ID: 31324682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    JBI Libr Syst Rev; 2008; 6(13):484-544. PubMed ID: 27820474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A relationship-based approach to improving clinical trials: The imCORE research network experience.
    MacKay Helou S; Gadberry C; Tran S; Zahara N; Talbot J; Vidhyarkorn T; Nickols C; Russell J; Otap D; Churchill S; Estrabaut M; Piggee J; Scher C
    Contemp Clin Trials; 2019 Nov; 86():105861. PubMed ID: 31669452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart failure: preventing disease and death worldwide.
    Ponikowski P; Anker SD; AlHabib KF; Cowie MR; Force TL; Hu S; Jaarsma T; Krum H; Rastogi V; Rohde LE; Samal UC; Shimokawa H; Budi Siswanto B; Sliwa K; Filippatos G
    ESC Heart Fail; 2014 Sep; 1(1):4-25. PubMed ID: 28834669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations.
    Courbier S; Dimond R; Bros-Facer V
    Orphanet J Rare Dis; 2019 Jul; 14(1):175. PubMed ID: 31300010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient and public involvement (PPI) in UK surgical trials: a survey and focus groups with stakeholders to identify practices, views, and experiences.
    Crocker JC; Pratt-Boyden K; Hislop J; Rees S; Locock L; Olszowski S; Chant A; Treweek S; Cook JA; Woolfall K; Farrar N; Bostock J; Bulbulia R
    Trials; 2019 Feb; 20(1):119. PubMed ID: 30744684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures.
    Morel T; Cano SJ
    Orphanet J Rare Dis; 2017 Nov; 12(1):171. PubMed ID: 29096663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations.
    Jones S; Flewett M; Flewett R; Lee S; Vick B; Thompson M; Pinnetti S; Zoz DF; Hoffmann-Vold AM; Kreuter M; Maher TM
    ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37260456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug Development.
    Jalowsky M; Hauber B; Scott MJ; Arkin S; Coulter JR; Watt SJ; Kelly LMG; Valentine A
    J Patient Exp; 2023; 10():23743735231213767. PubMed ID: 38026068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond the disease itself: A cross-cutting educational initiative for patients and families with rare diseases.
    Rovira-Moreno E; Abuli A; Codina-Sola M; Valenzuela I; Serra-Juhe C; Cuscó I; Borregán M; Cueto-González A; Vendrell T; López-Grondona F; Brun-Gasca C; Brignani E; Martínez-Ribot L; Garci-Espejo R; Cruz J; García-Arumí E; Tizzano EF
    J Genet Couns; 2021 Jun; 30(3):693-700. PubMed ID: 33142000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Redefining feasibility in clinical trials: Collaborative approaches for improved site selection.
    Bruneau B; Surdam K; Bland A; Krueger A; Wise A; Cotarlan A; Leviton A; Jouravleva E; Fitzgerald G; Frost HN; Cutler HF; Buddle J; Diaz LG; Cohen M; Sacco NA; Washington R; Mauermann S; Chen V; Bastek A
    Contemp Clin Trials Commun; 2024 Aug; 40():101291. PubMed ID: 39105082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Ultramarathon of Gene Therapy Development for Rare Diseases: How Can We Cross the Finish Line Together?
    Ward E
    Clin Ther; 2022 Aug; 44(8):1038-1044. PubMed ID: 35963801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.